体外生命支持后长期生存与生活质量:10年报告
基于雷根斯堡ECMO登记数据库2006—2015年十年数据,回顾性比较接受心脏外科干预(CS=189例)与未接受(w/oCS=307例)的体外生命支持患者,并通过电话访谈和EuroQol五维问卷评估生活质量。w/oCS组出院生存率高于CS组,但倾向评分匹配后差异不再显著;出院患者1年和2年生存率两组相近。
要点
- w/oCS组出院生存率41.7%高于CS组29.5%,匹配后差异不再显著
- 出院患者1年、2年生存率w/oCS组67%、50%,CS组60%、45%
- 受访者生活质量指数低于年龄匹配常模,仅25%重返工作或学习
核心结论
- 体外生命支持患者长期生存率可接受,未接受手术者可能有优势,但生活质量收窄,结果令人鼓舞但仍需改善。
研究设计与样本
- 回顾性分析雷根斯堡ECMO登记数据库2006—2015年十年数据,比较心脏外科干预组(CS=189例)与未干预组(w/oCS=307例),辅以电话访谈和EuroQol五维问卷生活质量分析。
主要发现
- w/oCS组出院生存率高于CS组(41.7% vs 29.5%;P=0.004),Kaplan-Meier分析支持w/oCS组(log rank P=0.02),倾向评分匹配后差异不再显著(P=0.07)。
- 出院患者1年和2年生存率w/oCS组为67%和50%,CS组为60%和45%(log rank P=0.29)。
- 两组EuroQol五维指数无差异,但均显著低于年龄匹配常模。
临床怎么用
- 对体外生命支持存活者应关注长期生活质量与功能康复,而不仅限于生存率。
- 出院后随访中可评估活动能力与重返工作需求,并提供相应康复支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Information is lacking about long-term survival and quality of life (QOL) after treating patients on extracorporeal life support. METHODS: Outcome data were assessed by phone interviews, a QOL analysis using the EuroQol 5-dimensions questionnaire and a retrospective inquiry of the Regensburg ECMO Registry database for the decade 2006-2015. A statistical analysis was obtained by comparing patients with a cardiosurgical intervention (CS = 189 patients) with those without (w/oCS = 307 patients). RESULTS: Survival to discharge in the w/oCS group was higher than that in the CS group (w/oCS: 41.7% vs CS: 29.5%; P = 0.004). A Kaplan-Meier analysis showed a significant difference between both groups in favour of patients w/oCS (log rank P = 0.02). This difference was no longer statistically significant after propensity score matching ( P = 0.07). The 1- and 2-year survival rates of discharged patients were 67% and 50% in the w/oCS group vs 60% and 45% in the CS group (log rank P = 0.29). Eighty-two patients answered the QOL questionnaire after a mean follow-up time of 4.2 ± 2.9 years. A total of 75% could handle their daily life; 57% were not limited in their usual activities. Mobility impairment was noted in 50%; 25% returned to work or school. There were no differences in the EuroQol 5-dimension indices between the patient groups. However, compared to a normative age-matched population, significantly lower indices were calculated. CONCLUSIONS: Long-term survival rates in patients requiring extracorporeal life support are acceptable with a probable advantage for patients without an operation and a narrowed QOL. The results are promising and encouraging, but there is also a need for improvement.
引用
- Camboni D, Philipp A, Rottenkolber V, et al. Long-term survival and quality of life after extracorporeal life support: a 10-year report. Eur J Cardiothorac Surg. 2017. PMID: 28525550. doi:10.1093/ejcts/ezx100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。